- Home
- FENC vs VNME Comparison
FENC vs VNME Comparison
Compare FENC & VNME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FENC
- VNME
- Stock Information
- Founded
- FENC 1996
- VNME 2025
- Country
- FENC United States
- VNME United States
- Employees
- FENC N/A
- VNME N/A
- Industry
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- VNME Blank Checks
- Sector
- FENC Health Care
- VNME Finance
- Exchange
- FENC Nasdaq
- VNME Nasdaq
- Market Cap
- FENC 225.4M
- VNME 255.4M
- IPO Year
- FENC 2001
- VNME 2025
- Fundamental
- Price
- FENC $9.70
- VNME $9.95
- Analyst Decision
- FENC Strong Buy
- VNME
- Analyst Count
- FENC 2
- VNME 0
- Target Price
- FENC $13.50
- VNME N/A
- AVG Volume (30 Days)
- FENC 88.7K
- VNME 31.7K
- Earning Date
- FENC 11-06-2025
- VNME 01-01-0001
- Dividend Yield
- FENC N/A
- VNME N/A
- EPS Growth
- FENC N/A
- VNME N/A
- EPS
- FENC N/A
- VNME N/A
- Revenue
- FENC $33,302,000.00
- VNME N/A
- Revenue This Year
- FENC $0.18
- VNME N/A
- Revenue Next Year
- FENC $52.59
- VNME N/A
- P/E Ratio
- FENC N/A
- VNME N/A
- Revenue Growth
- FENC N/A
- VNME N/A
- 52 Week Low
- FENC $3.96
- VNME $9.89
- 52 Week High
- FENC $9.92
- VNME $9.95
- Technical
- Relative Strength Index (RSI)
- FENC 65.13
- VNME N/A
- Support Level
- FENC $8.26
- VNME N/A
- Resistance Level
- FENC $9.70
- VNME N/A
- Average True Range (ATR)
- FENC 0.40
- VNME 0.00
- MACD
- FENC 0.11
- VNME 0.00
- Stochastic Oscillator
- FENC 90.58
- VNME 0.00
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
About VNME Vendome Acquisition Corporation I Class A Ordinary Shares
Vendome Acquisition Corp I is a blank check company.